FolioLanternBeta
KROSKeros Therapeutics, Inc.

Annita Tanini

Corp. Controller & VP, Finance at Keros Therapeutics, Inc., as of Aug 20, 2026Sold $13K of stock in the past 12 months: 100% to cover taxes.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
3.6%
share of stake sold at Keros Therapeutics, Inc.
45K
shares held after the latest filing, Keros Therapeutics, Inc.
Vested shares reported on Forms 3, 4 and 5 only. Not the insider's whole wealth.
1
company filed for

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

To cover taxesOne dollar scale for every month; the tallest bar is labeled
OctNovDecJanFebMarAprMayJunJulAug 2026: $13K to cover taxes$13KAugSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Keros Therapeutics, Inc. (KROS)Corp. Controller & VP, FinanceAug 13, 2026Aug 20, 2026

Recent filings

The last day with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.